111 Other Current Liabilities 2018-2025 | YI
111 other current liabilities from 2018 to 2025. Other current liabilities can be defined as field containing the sum of all current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
| 111 Annual Other Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 111 Quarterly Other Current Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | |
| 2024-12-31 | |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-09-30 | |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.060B | $1.973B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.937B | 59.72 |
| Hims & Hers Health (HIMS) | United States | $13.490B | 140.16 |
| Doximity (DOCS) | United States | $11.213B | 51.91 |
| Tempus AI (TEM) | United States | $10.091B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.366B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.822B | 59.72 |
| Hinge Health (HNGE) | United States | $3.402B | 0.00 |
| Privia Health (PRVA) | United States | $2.375B | 162.33 |
| 10x Genomics (TXG) | United States | $1.724B | 0.00 |
| Phreesia (PHR) | United States | $1.614B | 0.00 |
| Enovis (ENOV) | United States | $1.561B | 8.70 |
| Schrodinger (SDGR) | United States | $1.553B | 0.00 |
| Azenta (AZTA) | United States | $1.553B | 72.17 |
| Clover Health Investments (CLOV) | United States | $1.471B | 0.00 |
| Omnicell (OMCL) | United States | $1.387B | 24.48 |
| Evolent Health (EVH) | United States | $1.105B | 94.10 |
| Claritev (CTEV) | United States | $0.635B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.535B | 0.00 |
| Standard BioTools (LAB) | United States | $0.528B | 0.00 |
| Veradigm (MDRX) | United States | $0.503B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.453B | 0.00 |
| Talkspace (TALK) | United States | $0.420B | 125.50 |
| TruBridge (TBRG) | United States | $0.328B | 728.00 |
| Outset Medical (OM) | United States | $0.311B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.273B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.255B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.218B | 0.00 |
| CapsoVision (CV) | United States | $0.210B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.182B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| American Well (AMWL) | United States | $0.129B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.117B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.82 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.079B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.078B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.042B | 0.00 |
| HeartBeam (BEAT) | United States | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |